Form 4: Guardant Health Executive Darya Chudova Reports Stock Transactions
SEC Form 4 Filing
Darya Chudova, Chief Technology Officer of Guardant Health, reports the vesting of restricted stock units and associated tax withholding.
Summary
- On March 1, 2024, Darya Chudova, Chief Technology Officer of Guardant Health, Inc., reported transactions involving common stock.
- 316 shares were acquired upon the vesting of restricted stock units.
- 130 shares were withheld by the company to cover tax obligations related to the vesting of the restricted stock units at a price of $18.97.
- Following these transactions, Chudova directly owns 35,491 shares of Guardant Health common stock and 1,894 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they relate to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 11/02/2021 | Date the restricted stock unit award was granted. |
| 09/01/2022 | Shares vest in equal quarterly installments on the anniversary of this date. |
| 05/03/2023 | Darya Chudova elected as an executive officer. |
| 03/01/2024 | Date of the reported stock transactions (vesting of RSUs and tax withholding). |
| 03/04/2024 | Date of the signature on the Form 4 filing. |
| 09/01/2025 | Date the shares fully vest. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.